Jefferies & Co Initiates Coverage on Biotechnology and Drugs/Medical Supply Stocks
Tweet Send to a Friend
Jefferies & Co initiates coverage on Genomic Health (Nasdaq: GHDX) (PT $18) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


